Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer. Read more about Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer.
Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? Read more about Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?
Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California. Read more about Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California.
Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study. Read more about Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study.
Mammographic screening detects low-risk tumor biology breast cancers. Read more about Mammographic screening detects low-risk tumor biology breast cancers.
Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2. Read more about Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2.
Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Read more about Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery.
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer. Read more about Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer.
Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women. Read more about Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.
The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care. Read more about The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care.
